Dr. Hunsucker has studied and applied a wide variety of mass spectrometry approaches over the past twenty years. Since 2011 he has worked at Indi as Laboratory Director, where he is a key member of the team responsible for discovery and validation of the first protein-targeted multiplexed MRM MS assay to reach the clinic, Xpresysâ„¢ Lung. Earlier in his career, Dr. Hunsucker was a key member of the Biodesix team that commercialized a MALDI MS assay, now called Veristrat. He was responsible for establishing a clinical-grade assay in a CLIA-certified Mass Spectrometry laboratory. After receiving his Ph.D. in Analytical Chemistry from Virginia Tech, he joined the staff at the University of Colorado Denver School of Medicine, ultimately serving as Assistant Professor. While at UCD he was part of an international team that published the discovery and validation of Veristrat.